Primary neuroendocrine tumor of liver-a rare case report

Authors

  • Mohan Babu B. Department of Radiation Oncology, RIMS, Imphal, Manipur, India
  • Natasha Laishram Department of Radiation Oncology, RIMS, Imphal, Manipur, India
  • Laishram Purnima Devi
  • Sarmila Longjam Department of Radiation Oncology, RIMS, Imphal, Manipur, India
  • Ngairangbam Phalguni Singh Department of Radiation Oncology, RIMS, Imphal, Manipur, India
  • Farhana Tampakmayum Department of Radiation Oncology, RIMS, Imphal, Manipur, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20253995

Keywords:

Neuroendocrine tumor, Liver tumor, Synaptophysin

Abstract

The primary neuroendocrine tumor of the liver (PNET) is an exceptionally rare diagnosis, representing only 0.3% of all neuroendocrine tumors (NET). Due to its infrequency, accurate differentiation from other hepatic masses and exclusion of occult primary NETs are imperative. Establishing a definitive diagnosis of liver PNET often requires a comprehensive follow-up to rule out alternative primary causes. The liver is a frequent site for neuroendocrine metastases, and notably, primary neuroendocrine liver tumors typically demonstrate a more favorable prognosis compared to hepatocellular carcinoma and other malignant hepatic lesions. This paper reports on the case of a 74-year-old female patient who presented with pain in the right upper quadrant of the abdomen for two months. Following a triphasic CT scan and liver mass biopsy, the diagnosis of PNET was confirmed based on biopsy reports and immunohistochemistry (IHC). The patient underwent multimodality treatment; however, further intervention was deferred due to the patient's poor general condition. Instead, the patient was placed on the best supportive care.

 

Metrics

Metrics Loading ...

References

Chetty R. An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology. Arch Pathol Lab Med. 2008;132(8):1285-9. DOI: https://doi.org/10.5858/2008-132-1285-AOOPII

Quartey B. Primary hepatic neuroendocrine tumor: What do we know now? World J Oncol. 2011;2(5):209-16. DOI: https://doi.org/10.4021/wjon341w

Duc NM, Linh LT, Nguyen T, Nguyen NC, Vuong TH, Dao-Thi L, et al. Primary hepatic neuroendocrine tumor: Case report and literature review. Endocrinol Diabetes Metabol Case Rep. 2021;2021:20-0220. DOI: https://doi.org/10.1530/EDM-20-0220

Lv HY, Liu MX, Hong WT, Li XW. Primary hepatic neuroendocrine tumor with a suspicious pulmonary nodule: A case report and literature review. World J Clin Oncol. 2025;16(3):101236. DOI: https://doi.org/10.5306/wjco.v16.i3.101236

Costa AC, Santa-Cruz F, Guimarães H, Alexandre RP, Eduardo ACC, José-Luiz F, et al. Primary hepatic neuroendocrine tumor: A case report and literature review. Int J Surg Case Rep. 2020;72:1-4. DOI: https://doi.org/10.1016/j.ijscr.2020.05.057

Chen Q, Zhou J, Cai J, Hong Z, Jianjun Z, Xinyu B, et al. Primary hepatic neuroendocrine tumors: Retrospective study and literature review. Translational Cancer Res. 2018;7(2):428-40. DOI: https://doi.org/10.21037/tcr.2018.04.07

Maspero M, Rossi RE, Sposito C, Coppa J, Citterio D, Mazzaferro V. Long-term outcomes of resection versus transplantation for neuroendocrine liver metastases. Am J Transplantat. 2022;22(11):2598-607. DOI: https://doi.org/10.1111/ajt.17156

Lai Q, Feys E, Karam V, Adam R, Klempnauer J, Oliverius M, et al. (2024). Liver transplantation for the cure of neuroendocrine liver metastasis: A systematic review with particular attention to the risk factors of death and recurrence. Biomedicines. 2419;12(11):2419. DOI: https://doi.org/10.3390/biomedicines12112419

Downloads

Published

2025-11-28

How to Cite

B., M. B., Laishram, N., Laishram Purnima Devi, Longjam, S., Singh, N. P., & Tampakmayum, F. (2025). Primary neuroendocrine tumor of liver-a rare case report. International Journal of Research in Medical Sciences, 13(12), 5546–5549. https://doi.org/10.18203/2320-6012.ijrms20253995

Issue

Section

Case Reports